AMGEN INC is 71.9x more valuable than Tarsus Pharmaceuticals, Inc. by market capitalization ($191.70 B vs $2.67 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TARS | AMGN |
|---|---|---|
| Market cap | $2.67 B | $191.70 B |
| US-listed rank | #1923 | #79 |
| Revenue (latest FY) | $451.36M | $36.75B |
| Net income (latest FY) | -$66.00M | $7.71B |
| Net margin | -14.6% | 21.0% |
| P/E (trailing FY) | - | 24.9 |
| SEC filings | 617 | 1,011 |
AMGEN INC is 71.9x more valuable than Tarsus Pharmaceuticals, Inc. by market capitalization ($191.70 B vs $2.67 B).
In their latest fiscal years, Tarsus Pharmaceuticals, Inc. reported $451.36M in revenue while AMGEN INC reported $36.75B.
Full pages: Tarsus Pharmaceuticals, Inc. and AMGEN INC, or browse the full rankings.